Relationship of androgenic alopecia with higher BMI in Pakistan: A cross sectional study
Keywords:
Androgenetic, Alopecia, BMI, MetabolicAbstract
Objective  To determine the relationship of higher basal metabolic index (BMI) with severity of androgenic alopecia.  Methods  A hospital-based analytical cross-sectional study was done in men in the age group of 17-55 year. Weight and height were taken to determine BMI and Norwood scale was used to grade AGA.  Results  In this cross sectional study a total of 246 participants were included. Majority of them were (69.90%) of 31-40 years. Most of the men (45.10%) were in severe stage (6,7) of alopecia trailed by (43.09%) those having moderate stage (3,4,5). Most of them (62.60%) having AGA were obese (BMI > 30). Conclusion  Patients with severe AGA were significantly and strongly associated with higher BMI.References
References:
Yang CC, Hsieh FN, Lin LY, Hsu CK, Sheu HM, Chen W. Higher body mass index is associated with greater severity of alopecia in men with male-pattern androgenetic alopecia in Taiwan: a cross-sectional study. J Am AcadDermatol. 2014 Feb;70(2):297-302.
Yim, Elizabeth; Nole, Katherine L. Baquerizo; Tosti, Antonella (December 2014). "5α-Reductase inhibitors in androgenetic alopecia." Current Opinion in Endocrinology, Diabetes and Obesity. 2014 Dec. 21 (6): 493–498.
Stough D, Stenn K, Haber R, et al. Psychological effect, pathophysiology, and management of androgenetic alopecia in men. Mayo Clin Proc. 2005 Oct. 80(10):1316-22.
Yim E, Nole KL, Tosti A. 5α-Reductase inhibitors in androgenetic alopecia.CurrOpinEndocrinol Diabetes Obes. 2014 Dec;21(6):493-8.
Gok SO, Belli AA, Dervis E. Is There Really Relationship between Androgenetic Alopecia and Metabolic Syndrome?. Dermatology Research and Practice.2015:1-4.
Grover S. A study of patterns of androgenetic alopecia in men: an Indian perspective. Br J Dermatol. 2005;152(3):572-4.
Yi SM, Son SW, Lee KG, Kim SH, Lee SK, Cho ER et al. Gender-Specific Association of Androgenetic Alopecia With Metabolic Syndrome in a Middle-aged Korean Population. Br J Dermatol. 2012 Aug;167(2):306-13.
Hirsso P1, Laakso M, Matilainen V, Hiltunen L, Rajala U, Jokelainen J,et al. Association of insulin resistance linked diseases and hair loss in elderly men. Finnish population-based study. Cent Eur J Public Health. 2006 June; 14(2):78–81.
Lotufo PA1, Chae CU, Ajani UA, Hennekens CH, Manson JE. Male pattern baldness and coronary heart disease: the Physicians' Health Study. Arch Intern Med. 2000 Jan; 160(2).165–71.
Nanan D.J. The Obesity Pandemic - Implications for Pakistan. J Pak Med Assoc. 2002 Aug;52(8):342-6.
Norwood OT. Male pattern baldness: Classification and incidence. South Med J. 1975Nov;68(11):1359–70.
Hirsso P1, Laakso M, Matilainen V, Hiltunen L, Rajala U, Jokelainen J, et al. Association of insulin resistance linked diseases and hair loss in elderly men. Finnish population-based study. Cent Eur J Public Health. 2006 June; 14(2):78–81.
Matilainen V, Koskela P, Keinanen-Kiukaanniemi S. Early androgenetic alopecia as a marker of insulin resistance. Lancet 2000; 356(9236):1165–6.
Ahouansou S, Le Toumelin P, Crickx B, Descamps V. Association of androgenetic alopecia and hypertension. Eur J Dermatol 2007; 17(3):220–2.
Hirsso P1, Rajala U, Hiltunen L, Jokelainen J, Keinänen-Kiukaanniemi S, Näyhä S.. Obesity and low-grade inflammation among young Finnish men with early-onset alopecia. Dermatology 2007; 214(2):125–9.
